SCHEDULE: ADAR1 Capital Management Adjusts Freenome Stake

ADAR1 Capital Management, LLC, along with related entities and Daniel Schneeberger, have updated their beneficial ownership filings for Freenome, Inc., reporting a combined 8.3% stake as of June 30, 2026.

Summary

• ADAR1 Capital Management, LLC, ADAR1 Capital Management GP, LLC, and Daniel Schneeberger have filed an amended Schedule 13G, reporting their beneficial ownership of Freenome, Inc. Class A Ordinary Shares.
• As of June 30, 2026, the reporting persons collectively beneficially owned 674,695 shares, representing 8.3% of the outstanding Class A Ordinary Shares.
• This ownership includes shares held by ADAR1 Partners, LP (494,449 shares), Spearhead Insurance Solutions IDF, LLC (76,483 shares), and other separately managed accounts (103,763 shares).
• ADAR1 Capital Management, LLC acts as the investment manager for these entities and accounts, while ADAR1 Capital Management GP, LLC is the general partner of ADAR1 Partners, LP.
• Daniel Schneeberger, as manager of ADAR1 Capital Management, LLC and ADAR1 Capital Management GP, LLC, may be deemed to indirectly beneficially own these securities.
• The filing is based on 8,157,242 Class A Ordinary Shares outstanding as of June 30, 2026, as reported in Freenome's Form 10-Q filed on July 15, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting changes in beneficial ownership without significant new financial or strategic information.

Positives

• The filing clarifies the beneficial ownership structure for a significant stake in Freenome, Inc., providing transparency to investors.
• The reporting persons hold their shares in the ordinary course of business and not for the purpose of influencing control.

Negatives

• No new financial performance data or strategic updates are provided in this filing, limiting insights into the company's current operational status.

Risks

• The filing does not introduce new risks but relies on the existing risk disclosures within Freenome, Inc.'s other filings.

Future Outlook

This filing does not contain forward-looking statements or guidance from the company itself; it is a disclosure of ownership.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and investment managers accumulating significant stakes in public companies. This filing indicates ADAR1 Capital Management's continued interest in Freenome, Inc. within the biotechnology or diagnostics sector.

Stakeholder Impact

• Shareholders: Increased transparency regarding a significant beneficial owner's stake, which can influence market perception.

Next Steps

• ADAR1 Capital Management, LLC, ADAR1 Capital Management GP, LLC, and Daniel Schneeberger will continue to monitor their beneficial ownership levels and file amendments to Schedule 13G as required by SEC regulations.

Key Dates

Keywords

Freenome, Schedule 13G, Beneficial Ownership, ADAR1 Capital Management, Investment Management, Ordinary Shares, SEC Filing